Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1989;20:1449-1459

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Becker, P. S.
Right arrow Articles by Miller, V. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Becker, P. S.
Right arrow Articles by Miller, V. T.

Stroke, Vol 20, 1449-1459, Copyright © 1989 by American Heart Association


ARTICLES

Heparin-induced thrombocytopenia

PS Becker and VT Miller
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2182.

There are two types of heparin-induced thrombocytopenia. Type I is more common, has an early onset, and is mild, transient, and benign. Type I is due to direct heparin-induced platelet aggregation and is rarely associated with thromboembolic sequela. Type II is infrequent, has a late onset, and is more severe. Type II is due to an immune-mediated platelet aggregation caused by IgG and IgM that becomes bound to platelets. In Type II, the antibody titers decline over several months; however, early reexposure can result in a catastrophic secondary immune response. Frequently, Type II is associated with life- or limb- threatening thromboembolic complications (white clots), including stroke.


This article has been cited by other articles:


Home page
VASC ENDOVASCULAR SURGHome page
E. L. Dupont, V. Gahtan, and J. L. Mills
Heparin-Induced Thrombocytopenia: An Jatrogenic Catastrophe
Vascular and Endovascular Surgery, January 1, 1999; 33(1): 43 - 49.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
H. S Markus and H. Hambley
Neurology and the blood: haematological abnormalities in ischaemic stroke
J. Neurol. Neurosurg. Psychiatry, February 1, 1998; 64(2): 150 - 159.
[Full Text] [PDF]


Home page
ANGIOLOGYHome page
D.M.S. Boon, J.J. Michiels, H.L.J. Tanghe, and M.C. Kappers-Klunne
Heparin-Induced Thrombocytopenia with Multiple Cerebral Infarctions Simulating Thrombotic Thrombocytopenic Purpura A Case Report
Angiology, April 1, 1996; 47(4): 407 - 411.
[Abstract] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
M. K. Batra, M. D. Adolph, J. C. Thornton, A. M. Byramjee, A. O. Oliver, and H. Schreiber
Antithrombin III Deficiency and White Clot Syndrome: Case Reports and Literature Review
Vascular and Endovascular Surgery, January 1, 1996; 30(1): 37 - 44.
[Abstract] [PDF]


Home page
StrokeHome page
E. V. van Zuilen, F. L. Moll, F. E.E. Vermeulen, H. W. Mauser, J. van Gijn, and R. G.A. Ackerstaff
Detection of Cerebral Microemboli by Means of Transcranial Doppler Monitoring Before and After Carotid Endarterectomy
Stroke, February 1, 1995; 26(2): 210 - 213.
[Abstract] [Full Text]